SGMO – sangamo therapeutics, inc. (US:NASDAQ)

DELAYED


Volume Shares
1 Day Range
Volume Ratio
52 Week High
52 Week Low


VWAP
Today’s Volatility
20 Days Volatility
Open
Prior Close

YTD

1 Day

SGMO

SPY

QQQ

Swipe to see more

Main News & Impact Reports

Date

Time

Symbol

Headline

Impact

12/12

04:39 am

sgmo

How the Narrative Surrounding Sangamo Therapeutics Is Shifting After New Regulatory and Valuation Signals [Yahoo! Finance]

Low Report

How the Narrative Surrounding Sangamo Therapeutics Is Shifting After New Regulatory and Valuation Signals [Yahoo! Finance]

Report

12/2

08:05 am

sgmo

Sangamo Therapeutics Receives U.S. FDA Fast Track Designation for ST-503 for the Treatment of Small Fiber Neuropathy

Medium Report

Sangamo Therapeutics Receives U.S. FDA Fast Track Designation for ST-503 for the Treatment of Small Fiber Neuropathy

Report

11/28

01:23 am

sgmo

How Recent Developments Are Rewriting the Story for Sangamo Therapeutics [Yahoo! Finance]

Low Report

How Recent Developments Are Rewriting the Story for Sangamo Therapeutics [Yahoo! Finance]

Report

11/21

09:38 am

sgmo

Sangamo Therapeutics Announces FDA Acceptance of BLA Rolling Submission Request for ST-920 in Fabry Disease [Yahoo! Finance]

Medium Report

Sangamo Therapeutics Announces FDA Acceptance of BLA Rolling Submission Request for ST-920 in Fabry Disease [Yahoo! Finance]

Report

11/21

08:05 am

sgmo

Sangamo Therapeutics Announces FDA Acceptance of BLA Rolling Submission Request for ST-920 in Fabry Disease

Low Report

Sangamo Therapeutics Announces FDA Acceptance of BLA Rolling Submission Request for ST-920 in Fabry Disease

Report

11/15

01:42 am

sgmo

Sangamo Therapeutics (NASDAQ:SGMO) was downgraded by analysts at Wall St

Medium Report

Sangamo Therapeutics (NASDAQ:SGMO) was downgraded by analysts at Wall St

Report

11/10

01:51 am

sgmo

Why Sangamo Therapeutics (SGMO) Is Down 21.1% After Steep Q3 Revenue Drop and Nasdaq Compliance Extension [Yahoo! Finance]

Medium Report

Why Sangamo Therapeutics (SGMO) Is Down 21.1% After Steep Q3 Revenue Drop and Nasdaq Compliance Extension [Yahoo! Finance]

Report

11/8

07:05 pm

sgmo

Why The Narrative Around Sangamo Therapeutics Is Shifting After Recent Analyst and FDA Updates [Yahoo! Finance]

Medium Report

Why The Narrative Around Sangamo Therapeutics Is Shifting After Recent Analyst and FDA Updates [Yahoo! Finance]

Report

Date

Time

Symbol

Company Name

Action

%Chg

11/6/2025

08:01 am

SGMO

sangamo therapeutics, inc.

MISS Report

4.6%

sangamo therapeutics, inc.

Report

8/7/2025

04:01 pm

SGMO

sangamo therapeutics, inc.

MISS Report

-5.3%

sangamo therapeutics, inc.

Report

5/12/2025

04:01 pm

SGMO

sangamo therapeutics, inc.

MISS Report

-38.4%

sangamo therapeutics, inc.

Report

3/17/2025

04:01 pm

SGMO

sangamo therapeutics, inc.

MISS Report

-17.8%

sangamo therapeutics, inc.

Report

Date

Time

Action

From

Firm

Impact

%Chg

11/7

08:07 am

Reiterates

Overweight

Equal Weight

Barclays PLC

Low

Report

-0.6%

Report

11/7

07:23 am

Downgrades

Overweight

Equal-Weight

Barclays

Low

Report

0.3%

Report

11/7

07:23 am

Downgrades

Overweight

Equal-Weight

Barclays

Low

Report

0.3%

Report

11/7

04:38 am

Downgrades

OVERWEIGHT

EQUAL WEIGHT

BARCLAYS

Low

Report

2.5%

Report

11/7

04:38 am

Downgrades

OVERWEIGHT

EQUAL WEIGHT

BARCLAYS

Low

Report

2.5%

Report

Date

Time

Symbol

Headline

Impact

11/26

04:10 pm

sgmo

Form 4 SANGAMO THERAPEUTICS, For: Nov 24 Filed by: Jain Nikunj

Low Report

Form 4 SANGAMO THERAPEUTICS, For: Nov 24 Filed by: Jain Nikunj

Report

11/26

04:09 pm

sgmo

Form 4 SANGAMO THERAPEUTICS, For: Nov 24 Filed by: Willoughby Scott B.

Low Report

Form 4 SANGAMO THERAPEUTICS, For: Nov 24 Filed by: Willoughby Scott B.

Report

11/26

04:08 pm

sgmo

Form 4 SANGAMO THERAPEUTICS, For: Nov 24 Filed by: Macrae Sandy

Low Report

Form 4 SANGAMO THERAPEUTICS, For: Nov 24 Filed by: Macrae Sandy

Report

11/26

04:07 pm

sgmo

Form 4 SANGAMO THERAPEUTICS, For: Nov 24 Filed by: Duraibabu Prathyusha

Low Report

Form 4 SANGAMO THERAPEUTICS, For: Nov 24 Filed by: Duraibabu Prathyusha

Report

11/26

04:06 pm

sgmo

Form 4 SANGAMO THERAPEUTICS, For: Nov 24 Filed by: Dubois-Stringfellow Nathalie

Low Report

Form 4 SANGAMO THERAPEUTICS, For: Nov 24 Filed by: Dubois-Stringfellow Nathalie

Report

11/26

04:05 pm

sgmo

Form 4 SANGAMO THERAPEUTICS, For: Nov 24 Filed by: Davis Gregory D

Low Report

Form 4 SANGAMO THERAPEUTICS, For: Nov 24 Filed by: Davis Gregory D

Report

11/12

02:35 pm

sgmo

Form SCHEDULE 13G/A SANGAMO THERAPEUTICS, Filed by: WASATCH ADVISORS LP

Low Report

Form SCHEDULE 13G/A SANGAMO THERAPEUTICS, Filed by: WASATCH ADVISORS LP

Report

11/6

08:07 am

sgmo

Form 10-Q SANGAMO THERAPEUTICS, For: Sep 30

Low Report

Form 10-Q SANGAMO THERAPEUTICS, For: Sep 30

Report

Stock Stats

News Stats
All News
News Wires
Media Monitoring
SEC Edgar Filings
Upgrades
Downgrades
Initiated
Reiterated
Last Earnings
Last Earnings EPS
Next Earnings

Order Stats
Sub-Penny

Odd lot

Avg. bid-ask spread

Avg. bid-ask size

Shares at ask/bid

Off exchange

Main News & Impact Reports

Don’t Miss Out On The Next BIG Stock Move

Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below:

In short, News Quantified specializes in matching financial news with market data. We've analyzed 10s of millions of news events and know exactly which ones have an outsized impact on stock prices. So every single time a news item is released we know exactly what the average effect will be on a particular stock.